Clinical trial
Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
NCT03756051 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Harms of Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2018
- Completion date
- June 30, 2022
- Enrollment
- 2,871 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.